CRL
insider transactionsCHARLES RIVER LABORATORIES INTERNATIONAL, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
EVP & Chief People Officer
$23.2K
148 sh · $156.73
Own -1%
-
Other·F
CEVP, Disc & Safety Assessment
$16.5K
105 sh · $156.73
Own -1%
-
Other·F
EVP, Chief Information Officer
$7.4K
47 sh · $156.73
Own -1%
-
Other·F
Girshick Birgit KEY
Chief Executive Officer
$37.9K
242 sh · $156.73
Own -1%
-
Other·F
SVP, Finance and CAO
$5.8K
37 sh · $156.73
Own -0%
-
Other·F
EVP, Corp Strategy & Develop
$29.0K
185 sh · $156.73
Own -1%
-
Other·F
EVP & Chief People Officer
$31.7K
198 sh · $160.30
Own -1%
-
Other·F
CEVP, Disc & Safety Assessment
$26.9K
168 sh · $160.30
Own -2%
-
Other·F
EVP, Chief Information Officer
$10.3K
64 sh · $160.30
Own -1%
-
Other·F
Girshick Birgit KEY
Chief Executive Officer
$60.3K
376 sh · $160.30
Own -1%
-
Other·F
SVP, Finance and CAO
$8.0K
50 sh · $160.30
Own -0%
-
Other·F
EVP, Corp Strategy & Develop
$39.0K
243 sh · $160.30
Own -1%
-
Other·G
Director
$0
4.0K sh
Own -50%
-
Other·G
Director
$0
4.0K sh
Own -73%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +152%
-
Grant·A
Director
$249.9K
1.4K sh · $177.62
Own +9%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +10%
-
Grant·A
Director
$79.9K
450 sh · $177.62
Own +7%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +30%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +152%
-
Grant·A
Director
$95.0K
535 sh · $177.62
Own +13%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +56%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +29%
-
Grant·A
Director
$75.0K
422 sh · $177.62
Own +0%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +1%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +36%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +60%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +152%
-
Grant·A
Director
$255.4K
1.4K sh · $177.62
Own +101%
-
Grant·A
Coleman Glenn KEY
EVP & Chief Financial Officer
$3.5M
21.1K sh · $165.78
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 27, 2026 | Creamer Victoria L | Other F | 148 | $23.2K |
| May 27, 2026 | Parisotto Shannon M | Other F | 105 | $16.5K |
| May 27, 2026 | Mintz Mark | Other F | 47 | $7.4K |
| May 27, 2026 | Girshick Birgit KEY | Other F | 242 | $37.9K |
| May 27, 2026 | Knell Michael Gunnar | Other F | 37 | $5.8K |
| May 27, 2026 | LaPlume Joseph W | Other F | 185 | $29.0K |
| May 26, 2026 | Creamer Victoria L | Other F | 198 | $31.7K |
| May 26, 2026 | Parisotto Shannon M | Other F | 168 | $26.9K |
| May 26, 2026 | Mintz Mark | Other F | 64 | $10.3K |
| May 26, 2026 | Girshick Birgit KEY | Other F | 376 | $60.3K |
| May 26, 2026 | Knell Michael Gunnar | Other F | 50 | $8.0K |
| May 26, 2026 | LaPlume Joseph W | Other F | 243 | $39.0K |
| May 12, 2026 | Andrews Nancy C | Other G | 4.0K | $0 |
| May 12, 2026 | Andrews Nancy C | Other G | 4.0K | $0 |
| May 8, 2026 | Ceesay Abraham | Grant A | 1.4K | $255.4K |
| May 8, 2026 | MACKAY MARTIN | Grant A | 1.4K | $249.9K |
| May 8, 2026 | MACKAY MARTIN | Grant A | 1.4K | $255.4K |
| May 8, 2026 | Llado George Sr. | Grant A | 450 | $79.9K |
| May 8, 2026 | Llado George Sr. | Grant A | 1.4K | $255.4K |
| May 8, 2026 | Enyedy Mark J | Grant A | 1.4K | $255.4K |
| May 8, 2026 | Kemps-Polanco Reshema | Grant A | 535 | $95.0K |
| May 8, 2026 | Kemps-Polanco Reshema | Grant A | 1.4K | $255.4K |
| May 8, 2026 | WILSON VIRGINIA M | Grant A | 1.4K | $255.4K |
| May 8, 2026 | FOSTER JAMES C | Grant A | 422 | $75.0K |
| May 8, 2026 | FOSTER JAMES C | Grant A | 1.4K | $255.4K |
| May 8, 2026 | Andrews Nancy C | Grant A | 1.4K | $255.4K |
| May 8, 2026 | Thompson Craig B. | Grant A | 1.4K | $255.4K |
| May 8, 2026 | Graves Paul W | Grant A | 1.4K | $255.4K |
| May 8, 2026 | Barg Steven | Grant A | 1.4K | $255.4K |
| May 1, 2026 | Coleman Glenn KEY | Grant A | 21.1K | $3.5M |
About CRL insider trading
This page tracks insider transactions for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.